MARATHON PATENT GROUP (MARA) August 14, 2015 David HoffFounderiphawk@outlook.com Q2 2015 Preview IP HAWK David Hoffiphawk@outlook.com @theiphawk http://theiphawk.blogspot.com IamlongMARA.IhavenotbeenpaidtoprepareordisseminatethisreportbyMarathonoranycompanydiscussed.Allinformationhasbeenobtainedfrom public sources.All opinions are my own.Please consult a financial advisor before making any financial decisions.Thoughts From the Hawk Key Data Price$2.90 TTM Revenue$22.72mm Enterprise Value$57.04mm Shares Outstanding14.06mm Shares Fully Diluted19.56mm Float10.28mm 52 Week Range$2.31-9.73 3 Month Avg. Volume103,332 Marathon Patent Group will announce earnings tonight after the market closes at 4PM.A conference call will be held on Monday August 17, 2015 at 8:30am EST.I am expecting revenue in the $1.3mm range based on announced patent licenses this quarter and the portfolio/defendant.The company has yet to land a premium license in the eight figure range so far in 2015. Q2 Developments: Lost a trial in their IP Liquidity portfolio in regards to the TPMS patents to Schrader Filed litigation versus Yahoo in Germany with a TLI Communication patent Added Richard Chernicoff to the Board of Directors Received a Markman Opinion and trial scheduling order in the Signal IP portfolio Acquired an international portfolio of 43 patents related to TPMS patents Received a favorable ruling on validity (nullity) in Germany with a Medtech patent asserted against Stryker Negative Markman Opinion issued in the Andrulis portfolio v Celgene finding claim terms indefinite. MARATHON PATENT GROUP (MARA) August 14, 2015 David HoffFounderiphawk@outlook.com Revenue Estimate by Agreement IP HAWK David Hoffiphawk@outlook.com @theiphawk http://theiphawk.blogspot.com IamlongMARA.IhavenotbeenpaidtoprepareordisseminatethisreportbyMarathonoranycompanydiscussed.Allinformationhasbeenobtainedfrom public sources.All opinions are my own.Please consult a financial advisor before making any financial decisions.PortfolioLicenseeCase StatusEstimated Amount Medtech / OrthophoenixNot DisclosedGerman LitigationN/A Medtech / OrthophoenixDirect FlowGerman Litigation$200,000 Selene CommunicationsThomson ReutersClaims Construction$200,000 E2E ProcessingNordstromClaims Construction$200,000 E2E ProcessingCrocsClaims Construction$200,000 E2E ProcessingHallmarkClaims Construction$200,000 Signal IPJaguar Land RoverAfter Markman Opinion$300,000 $1,300,000 + unknown Medtech litigation MARATHON PATENT GROUP (MARA) August 14, 2015 David HoffFounderiphawk@outlook.com Q2 Developments and Conference Call Questions IP HAWK David Hoffiphawk@outlook.com @theiphawk http://theiphawk.blogspot.com IamlongMARA.IhavenotbeenpaidtoprepareordisseminatethisreportbyMarathonoranycompanydiscussed.Allinformationhasbeenobtainedfrom public sources.All opinions are my own.Please consult a financial advisor before making any financial decisions. The company went to trial in their TPMS systems patents (IP Liquidity), which a jury rendered a verdict on June 11, 2015 finding the patents not invalid, but finding that Schrader did not infringe the patents in suit. A Markman Opinion was issued in the Signal IP portfolio on April 20th, 2015 that was mostly favorable to the patents in suit.The company has subsequently settled with two defendants.A trial scheduling order was also entered on June 12, which will see a number of trials starting in March 2016.More details can be found on the companies web page. Marathon announced the acquisition of 43 international patents on May 15, 2015.My questions include purchase price, which should be disclosed in the financials and the status of the cases filed in Germany, which will need to be asked on the conference call.Per the press release, infringement has already been decided in favor of Marathon, but investors need to know the status of the injunction and when a nullity trial will be held. The company entered into a forbearance agreement on July 21, 2015 in the Medtech portfolio.With the Fortress line of credit available, why wasnt it used instead of extending the note and issuing 200,000 restricted shares.I would like to hear more color on this issue. A summary judgment hearing was held in the Dynamic Advances v Apple trial in late July.Any status updated from that conference and possibly scheduling a trial for the end of the year or early 2016. Status of the pipeline of acquisitions and patent intake.The company has only purchased one portfolio so far this year in the international TPMS portfolio. Disclosure: I, David Hoff, own stock in MARA.I wrote this report myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in the article. DISCLOSURE: The information contained herein is not intended to be investment advice and does not constitute any form of invitation or inducement by David Hoff to engage in investment activity. Neither the information nor any opinion expressed constitutes a solicitation for the purchase or sale of any security. Securities, financial instruments, strategies, or commentary mentioned herein may not be suitable for all investors and this material is not intended for any specific investor and does not take into account an investors particular investment objectives, financial situations or needs. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only current as of the stated date of their issue. Prices, values, or income from any securities or investments mentioned in this report may fluctuate, and an investor may, upon selling an investment lose a portion of, or the entire principal amount invested. Past performance is no guarantee of future results. Before acting on any recommendation in this material, you should consider whether it is suitable for your particular circumstances and, if necessary, seek professional advice. FORWARD-LOOKING STATEMENT This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify me at iphawk@outlook.com. NO WARRANTY OR LIABILITY ASSUMED David Hoff is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. David Hoff has not been compensated for this report. No liability is accepted by David Hoff whatsoever for any direct, indirect or consequential loss arising from the use of this document. David Hoff expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. David Hoff does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. MARATHON PATENT GROUP (MARA) August 14, 2015 David HoffFounderiphawk@outlook.com Disclosure IP HAWK David Hoffiphawk@outlook.com @theiphawk http://theiphawk.blogspot.com